Palavras-chave
Como Citar
Resumo
The relationship between the use of combined oral contraceptives and the risk of cervical cancer in young women has been the subject of intense scrutiny in the scientific literature. This topic, which is extremely important for women's health, has sparked debates and investigations due to the prevalence of the use of these contraceptives and the significant incidence of cervical cancer in young women. Understanding this possible association is crucial to inform contraceptive practices and cervical cancer prevention strategies. Objective: To evaluate and consolidate the available evidence on the relationship between the use of combined oral contraceptives and the risk of cervical cancer in young women, using studies and articles published in the last 10 years. Methodology: strictly adhered to the PRISMA checklist, using the PubMed, Scielo and Web of Science databases to identify relevant studies. The selected descriptors were combined oral contraceptives, cervical cancer, young women, risk and association. The search covered articles published in the last 10 years. The inclusion criteria included studies that focused exclusively on young women, directly investigated the relationship between the use of combined oral contraceptives and cervical cancer, and were published in the last 10 years. On the other hand, studies with participants outside the specific age range, research that did not directly address the association in question and articles that were not fully available or did not qualify as systematic reviews or primary studies were excluded. This methodological approach provided a comprehensive and careful analysis of the existing evidence on the topic. Results: 18 articles were selected. Analysis of studies revealed a diversity of perspectives on the association between combined oral contraceptives and cervical cancer risk in young women. Key topics included possible biological mechanisms, variations in the types of contraceptives used, and the influence of confounding factors. Conclusion: Given the complexity of the data analyzed, this review highlights the need for careful approaches in interpreting the relationship between combined oral contraceptives and cervical cancer in young women. Future research is crucial to fully clarify this association and provide more precise guidance for clinical practice.
Referências
Oh HY, Kim MK, Seo SS, Lee JK. Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women. J Epidemiol. 2016;26(1):22-9. doi: 10.2188/jea.JE20150047.
Jordan SJ, Wilson LF, Nagle CM, Green AC, Olsen CM, Bain CJ, Pandeya N, Whiteman DC, Webb PM. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives. Aust NZJ Public Health. 2015 Oct;39(5):441-5. doi: 10.1111/1753-6405.12444.
Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel -Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno -de-Mesquita HB, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E , Castellsagué X. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016 Jan 25;11(1):e0147029. doi: 10.1371/journal.pone.0147029.
Fischer S, Kuebler U, Abbruzzese E, Breymann C, Mernone L, Ehlert U. Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence. BMC Cancer. 2022 Feb 5;22(1):145. doi: 10.1186/s12885-022-09247-3.
Balle C, Konstantinus IN, Jaumdally SZ, Havyarimana E, Lennard K, Esra R, Barnabas SL, Happel AU, Moodie Z, Gill K, Pidwell T, Karaoz U, Brodie E, Maseko V, Gamieldien H, Bosinger SE, Myer L , Bekker LG, Passmore JS, Jaspan HB. Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial. Nat Commun. 2020 Nov 4;11(1):5578. doi: 10.1038/s41467-020-19382-9.
Zhu C, Bassig BA, Zhang Y, Shi K, Boyle P, Li N, Zheng T. A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA. Eur J Cancer Prev. 2015 May;24(3):240-4. doi: 10.1097/CEJ.0000000000000062.
Wang B, Yang HD, Shi XH, Li H. Advanced uterine adenosarcoma with sarcomatous overgrowth in a young woman: A case report. Medicine (Baltimore). 2019 Nov;98(47):e18119. doi: 10.1097/MD.0000000000018119.
Tomao F, Corrado G, Peccatori FA, Boveri S, Preti EP, Colombo N, Landoni F. Fertility-Sparing Options in Young Women with Cervical Cancer. Curr Treat Options Oncol. 2016 Jan;17(1):5. doi: 10.1007/s11864-015-0386-9.
Wojtyla C, Janik-Koncewicz K, La Vecchia C. Cervical cancer mortality in young adult European women. Eur J Cancer. 2020 Feb;126:56-64. doi: 10.1016/j.ejca.2019.11.018.
Eastment MC, Gupta A, James J, Richardson BA, Pinder L, Kim HN, Wald A, Tsui JI. Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses. Subst Abus. 2022;43(1):925-931. doi: 10.1080/08897077.2021.2010257.
New-Aaron M, Meza JL, Goedert MH, Kibusi SM, Mkhoi ML, Mayengo CD, Charles J, Shabani S, Musil KM, Cheney A, Sumba S. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment. Asian Pac J Cancer Prev. 2020 Jul 1;21(7):2035-2045. doi: 10.31557/APJCP.2020.21.7.2035.
Marnitz S, Tsunoda AT, Martus P, Vieira M, Affonso Junior RJ, Nunes J, Budach V, Hertel H, Mustea A, Sehouli J, Scharf JP, Ulrich U, Ebert A, Piwonski I, Kohler C. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. Int J Gynecol Cancer. 2020 Dec;30(12):1855-1861. doi: 10.1136/ijgc-2020-001973.
Nyambe A, Lubeya MK. Cervical cancer and HIV in Zambian women. Lancet Glob Health. 2021 Jun;9(6):e734-e735. doi: 10.1016/S2214-109X(21)00230-8.
Al-Saadi AN, Al-Muqbali AH, Dawi E. Women's Knowledge of Cervical Cancer: A cross-sectional study in Al Buraimi Governorate, Oman. Sultan Qaboos Univ Med J. 2021 Aug;21(3):450-456. doi: 10.18295/squmj.4.2021.022.
Battagello J, Monetti D, Rizzato S, Rosano A, Stocco CF, Zamberlan S, Rugge M, Zorzi M. Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round. Epidemiol Prev. 2022 May-Jun;46(3):173-180. English. doi: 10.19191/EP22.3.A407.030.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Danillo Gondim da Silva Filho , Gabriela de Souza Martins , Luan Bernardino Montes Santos , Isabela Sousa Campos , Valdivino Soares de Oliveira Junior , Erika dos Santos Soares , Soraya de Souza Marques Leit , Natascha de Prado Soares, Thays Souza Cruz , Rafael Martins Bitanti , Cristiana Daniela de Souza , Bruna Martins Ribeiro , Daniella Afonso Borges , Leandro Rezende de Souza Júnior